肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 ESMO临床实践指南：成人急性髓性白血病的诊断，治疗和随访

2020-03-11 欧洲肿瘤内科学会 Ann Oncol. 2020 Mar 11.

急性髓系白血病

2020年3月，欧洲肿瘤内科学会(ESMO)发布了急性髓性白血病的诊断，治疗和随访指南，本文是对2013年版指南的更新，主要内涉及急性髓性白血病包括急性早幼粒细胞白血病的管理建议。

中文标题：

2020 ESMO临床实践指南：成人急性髓性白血病的诊断，治疗和随访

英文标题：

Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

发布机构：

欧洲肿瘤内科学会

发布日期：

2020-03-11

简要介绍：

2020年3月，欧洲肿瘤内科学会(ESMO)发布了急性髓性白血病的诊断，治疗和随访指南，本文是对2013年版指南的更新，主要内涉及急性髓性白血病包括急性早幼粒细胞白血病的管理建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=bea301c0018882f2, title=2020 ESMO临床实践指南：成人急性髓性白血病的诊断，治疗和随访, enTitle=Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up., guiderFrom=Ann Oncol. 2020 Mar 11., authorId=0, author=, summary=2020年3月，欧洲肿瘤内科学会(ESMO)发布了急性髓性白血病的诊断，治疗和随访指南，本文是对2013年版指南的更新，主要内涉及急性髓性白血病包括急性早幼粒细胞白血病的管理建议。, cover=https://img.medsci.cn/202049/1586434613340_2020535.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Wed Mar 11 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年3月，欧洲肿瘤内科学会(ESMO)发布了急性髓性白血病的诊断，治疗和随访指南，本文是对2013年版指南的更新，主要内涉及急性髓性白血病包括急性早幼粒细胞白血病的管理建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2579, tagName=急性髓系白血病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2579, guiderKeyword=急性髓系白血病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5222, appHits=265, showAppHits=31, pcHits=2086, showPcHits=4902, likes=1, shares=9, comments=5, approvalStatus=1, publishedTime=Thu Apr 09 20:59:28 CST 2020, publishedTimeString=2020-03-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Apr 09 20:17:01 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 03:42:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=976359, encodeId=bc149e635929, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/faddd3baeed349c89ef0e2c4a2af1c2f/ee7916de35bd438bafcb049da22068ab.jpg, createdBy=57961630561, createdName=发卡, createdTime=Wed Jun 23 22:39:04 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976106, encodeId=dbb49e610675, content=梅斯医学很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:32:49 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918958, encodeId=90109189589b, content=谢谢，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c7a5233084, createdName=147a4e60m70暂无昵称, createdTime=Fri Jan 22 11:37:05 CST 2021, time=2021-01-22, status=1, ipAttribution=)]
    2021-06-23 发卡

    赞

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=976359, encodeId=bc149e635929, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/faddd3baeed349c89ef0e2c4a2af1c2f/ee7916de35bd438bafcb049da22068ab.jpg, createdBy=57961630561, createdName=发卡, createdTime=Wed Jun 23 22:39:04 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976106, encodeId=dbb49e610675, content=梅斯医学很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:32:49 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918958, encodeId=90109189589b, content=谢谢，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c7a5233084, createdName=147a4e60m70暂无昵称, createdTime=Fri Jan 22 11:37:05 CST 2021, time=2021-01-22, status=1, ipAttribution=)]
    2021-06-23 湘雅科教

    梅斯医学很赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=976359, encodeId=bc149e635929, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/faddd3baeed349c89ef0e2c4a2af1c2f/ee7916de35bd438bafcb049da22068ab.jpg, createdBy=57961630561, createdName=发卡, createdTime=Wed Jun 23 22:39:04 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976106, encodeId=dbb49e610675, content=梅斯医学很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:32:49 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918958, encodeId=90109189589b, content=谢谢，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c7a5233084, createdName=147a4e60m70暂无昵称, createdTime=Fri Jan 22 11:37:05 CST 2021, time=2021-01-22, status=1, ipAttribution=)]
    2021-01-22 147a4e60m70暂无昵称

    谢谢，学习了

    0

相关指南

复发难治性急性髓系白血病中国诊疗指南（2017年版）

中华医学会血液学分会白血病淋巴瘤学组 · 2017-03-30

2013 加拿大共识：老年急性髓系白血病的治疗

国外血液科相关专家小组 · 2013-05-01

拓展阅读

2013 加拿大共识：老年急性髓系白血病的治疗

国外血液科相关专家小组 · 2013-05-01

复发难治性急性髓系白血病中国诊疗指南（2017年版）

中华医学会血液学分会白血病淋巴瘤学组 · 2017-03-30

2020 EBMT实践建议：造血干细胞移植治疗FLT3基因内部串联复制的急性髓系白血病

欧洲血液和骨髓移植小组(EBMT,European Group for Blood and Marrow Transplantation) · 2020-04-02

2022 EHA共识建议：成人急性髓系白血病新型靶向治疗的抗真菌预防

欧洲血液学协会(EHA,European Haematology Association) · 2022-05-09

2022 NICE 医疗技术指南：急性髓系白血病诱导治疗后口服阿扎胞苷维持治疗[TA827]

英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence) · 2022-10-05

2022 国际共识：急性髓系白血病的分类

国外血液科相关专家小组 · 2022-10-20